Moderna cuts five programmes to save $1.1bn in R&D costs
Moderna will slash five clinical programmes but says it remains on track for ten product approvals in the next three years.
Moderna will slash five clinical programmes but says it remains on track for ten product approvals in the next three years.
What's Your Reaction?
